drugset / Trial / NCT00237510

Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating

NCT00237510

Completed 15 enrolled Thomas Jefferson University
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is based on the hypothesis that terazosin, a blocker of alpha-1 receptors, will be effective in reducing excessive sweating caused by antidepressant treatment, and will have minimal adverse effects.

Timeline

Start
2005-05
Primary completion
2006-05
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Terazosin Small molecule

Indications

No indication recorded.